The decision to go south for the winter during the ongoing pandemic is a complex one, informed by factors such as availability of recreational opportunities and cost of living.
Like other innovations borne out of challenging times in history, the push for more automation and tele-operation triggered by the COVID-19 pandemic must mean more efficient and safer workplaces.
Giving money to support local production of COVID-19 vaccines is a step in the right direction if it will help in resuscitating Nigeria’s vaccine production laboratory.
Employers like Pimlico Plumbers may want to get authoritarian about vaccinating those who work for them, but they’ll have a hard time justifying it in court.
Vaccine developers pledge to create boosters that can better handle the new variants of the virus, and new data gives reassurance on the Oxford vaccine.
Michael Plank, University of Canterbury dan Shaun Hendy, University of Auckland, Waipapa Taumata Rau
A new study argues for selective border relaxations. But with COVID-19 more prevalent now than at almost any point in the past, the risk would be substantial.
Interim findings from the Independent Panel for Pandemic Preparedness and Response paint a bleak picture of global failure. If things don’t improve, a future pandemic could be truly catastrophic.
Public health officials and politicians have access to the same data on COVID-19 cases, deaths and transmission, but might arrive at different conclusions.
Joe Biden used the National Prayer Breakfast to call for unity amid ‘dark, dark times.’ The event has been attended by every president since Dwight Eisenhower in 1953.
Researchers are already working to improve the current crop of mRNA vaccines. Hopefully this will help them become more practical and affordable for the entire world, not just first-world countries.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand